Most Recent
Generic pharmaceutical firm Sandoz has won a temporary stay of a $26.3 million judgment in a patent case as it awaits a decision by the Commissioner of Patents regarding a licence to make a cheaper version of the bestselling antidepressant Lexapro.
The Commonwealth Department of Public Prosecutions has told the Federal Court it will "very significantly" reduce the number of criminal charges laid against mobility equipment supplier Country Care Group as the landmark cartel case heads to trial in October.
A judge has rejected a motion by the NSW government and 15 local health districts to shut down a class action by the relatives of overseas patients who were forced to serve as guarantors and hit with hospital bills worth tens of thousands of dollars.
The trial in the ACCC's case against hospital group Ramsay Health Care has doubled in length after the regulator made a late bid to enter as evidence a file note based on a sound recording of a meeting in which a Ramsay unit's CEO allegedly made anti-competitive threats.
A Mildura-based healthcare company and its boss have been committed to stand trial in the first criminal cartel case brought by the Australian Competition and Consumer Commission against an Australian business.
An eight-day joint hearing in cases brought by Allergan alleging infringement of its Botox trade mark, which was due to commence Monday, has been unexpectedly vacated by the court, with barristers and legal teams left in the dark about the reasons.
A surgeon who was considering opening a health clinic in Coffs Harbour, NSW recorded one of the meetings central to the competition watchdog's action against Ramsay Health, in which alleged anti-competitive threats were made by a CEO of two Ramsay units, a court has heard.
Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.
German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.